We are live on
!
Find out more
FCM
Frontier Capital Management Portfolio holdings
AUM
$10.7B
1-Year Est. Return
67.78%
This Fund
S&P 500
This Quarter
Est. Return
+21.14%
1 Year Est. Return
+67.78%
3 Year Est. Return
+183.84%
5 Year Est. Return
+266.8%
10 Year Est. Return
+1,486.88%
AUM
$14.1B
AUM Growth
+$1.68B
(+14%)
Cap. Flow
-$552M
Cap. Flow
% of AUM
-3.93%
Top 10 Holdings %
Top 10 Hldgs %
14.05%
Holding
318
New
31
Increased
95
Reduced
170
Closed
22
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Autodesk
ADSK
|
+$89.7M |
| 2 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$79.6M |
| 3 |
Microchip Technology
MCHP
|
+$79.2M |
| 4 |
DATA
Tableau Software, Inc.
DATA
|
+$67.4M |
| 5 |
Capri Holdings
CPRI
|
+$58.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qorvo
QRVO
|
+$120M |
| 2 |
WP
Worldpay, Inc.
WP
|
+$105M |
| 3 |
Semtech
SMTC
|
+$100M |
| 4 |
Aon
AON
|
+$68.2M |
| 5 |
O'Reilly Automotive
ORLY
|
+$58.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.95% |
| 2 | Healthcare | 17.21% |
| 3 | Industrials | 16.42% |
| 4 | Consumer Discretionary | 13.67% |
| 5 | Financials | 11.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICPT
251
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $6.66M | 0.05% |
+59,511
| New | +$6.5M |
|
|
INVX
252
Innovex International
INVX
$2.09B
| $6.42M | 0.05% |
140,084
-9,450
| -6% | -$371K |
|
|
CLDR
253
DELISTED
Cloudera, Inc.
CLDR
| $6.42M | 0.05% |
587,078
-976,150
| -62% | -$12.5M |
|
254
Alnylam Pharmaceuticals
ALNY
$31.9B
| $6.37M | 0.05% |
68,126
-129,743
| -66% | -$10.9M |
|
|
DPLO
255
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $6.35M | 0.05% |
1,092,180
-73,847
| -6% | -$763K |
|
256
Appian
APPN
$2.72B
| $6.16M | 0.04% |
178,851
-105,015
| -37% | -$3.55M |
|
|
NEWR
257
DELISTED
New Relic, Inc.
NEWR
| $5.95M | 0.04% |
60,285
-77,879
| -56% | -$7.71M |
|
|
COUP
258
DELISTED
Coupa Software Incorporated
COUP
| $5.84M | 0.04% |
64,217
-98,750
| -61% | -$8.46M |
|
|
MASI
259
DELISTED
Masimo
MASI
| $5.66M | 0.04% |
40,935
-16,441
| -29% | -$2.06M |
|
|
CY
260
DELISTED
Cypress Semiconductor
CY
| $5.62M | 0.04% |
376,439
-521,818
| -58% | -$7.57M |
|
261
Stoneridge
SRI
$205M
| $5.45M | 0.04% |
+188,928
| New | +$5.17M |
|
|
LTHM
262
DELISTED
Livent Corporation
LTHM
| $5.38M | 0.04% |
+438,153
| New | +$5.71M |
|
|
HOME
263
DELISTED
At Home Group Inc.
HOME
| $5.26M | 0.04% |
+294,551
| New | +$6.53M |
|
|
NE
264
DELISTED
Noble Corporation
NE
| $5.14M | 0.04% |
1,791,851
-121,364
| -6% | -$378K |
|
265
TD Synnex
SNX
$21B
| $4.65M | 0.03% |
+97,440
| New | +$4.61M |
|
266
Cushman & Wakefield Ltd
CWK
$2.94B
| $4.22M | 0.03% |
237,265
-382,848
| -62% | -$6.6M |
|
|
NVRO
267
DELISTED
NEVRO CORP.
NVRO
| $4.21M | 0.03% |
+67,364
| New | +$3.17M |
|
|
ENT
268
DELISTED
Global Eagle Entertainment Inc.
ENT
| $4.21M | 0.03% |
237,364
+11,294
| +5% | +$643K |
|
|
HA
269
DELISTED
Hawaiian Holdings, Inc.
HA
| $4M | 0.03% |
152,176
-10,166
| -6% | -$295K |
|
270
Karyopharm Therapeutics
KPTI
$34.9M
| $3.99M | 0.03% |
45,558
+34,498
| +312% | +$3.82M |
|
|
SGMO
271
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $3.96M | 0.03% |
415,256
-28,130
| -6% | -$287K |
|
|
PVTL
272
DELISTED
Pivotal Software, Inc.
PVTL
| $3.73M | 0.03% |
178,659
+17,395
| +11% | +$340K |
|
273
Healthcare Realty
HR
$6.39B
| $3.68M | 0.03% |
128,725
-27,749
| -18% | -$772K |
|
|
AYX
274
DELISTED
Alteryx Inc
AYX
| $3.6M | 0.03% |
42,944
+34,324
| +398% | +$2.48M |
|
275
Alkermes
ALKS
$7.72B
| $3.34M | 0.02% |
+91,507
| New | +$3.02M |
|
Similar funds
VAS
SIM
FMI
HL
RCMF
DPIM
CA
SCM
Frontier Capital Management's Q1 2019 Portfolio in Review
As of Q1 2019, Frontier Capital Management held 318 positions worth $14.1B, up 14% from $12.4B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Frontier Capital Management withdrew a net $552M in Q1 2019, closing 22 positions and reducing 170 holdings. Its most notable exit was Openlane, an estimated $53.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Frontier Capital Management opened a new position in Autodesk worth $93.5M.
- Frontier Capital Management's largest Q1 2019 buy was Autodesk: 600,162 shares worth $93.5M.
- Frontier Capital Management added most to Tableau Software, Inc. in Q1 2019, an estimated $67.4M increase.
- Frontier Capital Management's biggest Q1 2019 reduction was Qorvo, cutting an estimated $120M.
- Frontier Capital Management fully exited Openlane in Q1 2019, selling an estimated $53.4M.
- Frontier Capital Management's ten largest holdings make up 14% of its $14.1B portfolio in Q1 2019.
- Frontier Capital Management opened 31 new positions and closed 22 in Q1 2019.
- Frontier Capital Management's portfolio value rose 14% quarter-over-quarter to $14.1B.
Based on Frontier Capital Management's 13F filing for Q1 2019, filed 7 May 2019.